Skip to main content
Top
Published in: International Journal of Legal Medicine 3/2019

01-05-2019 | Short Communication

Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry

Authors: Hyewon Seo, In Sook Kim, Young-Hoon Kim, Hye Hyun Yoo, Jin Hong

Published in: International Journal of Legal Medicine | Issue 3/2019

Login to get access

Abstract

2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine (25N-NBOMe, 2C-N-NBOMe, NBOMe-2C-N) is a novel synthetic psychoactive substance of the phenethylamine chemical class. A few metabolism studies have been conducted for 25I-NBOMe, 25B-NBOMe, and 25C-NBOMe, and others, whereas 25N-NBOMe metabolism has not been researched. In this study, the in vitro metabolism of 25N-NBOMe was investigated with human liver microsomes, and the reaction mixture was analyzed using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS). Formation of 14 metabolites (M1–M14) was yielded with incubation of 25N-NBOMe in human liver microsomes in the presence of NADPH. The metabolites were structurally characterized on the basis of accurate mass analysis and MS/MS fragmentation patterns. The biotransformations included hydroxylation, O-demethylation, N-dealkylation, nitro reduction, dehydrogenation, carbonylation, and combinations thereof. Hydroxyl metabolite was the most abundant compound after the phase I process. These results provide helpful information establishing biomarkers in case of 25N-NBOMe ingestion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Welter-Luedeke J, Maurer HH (2016) New psychoactive substances: chemistry, pharmacology, metabolism, and detectability of amphetamine derivatives with modified ring systems. Ther Drug Monit 38:4–11CrossRef Welter-Luedeke J, Maurer HH (2016) New psychoactive substances: chemistry, pharmacology, metabolism, and detectability of amphetamine derivatives with modified ring systems. Ther Drug Monit 38:4–11CrossRef
3.
go back to reference Wood DM, Sedefov R, Cunningham A, Dargan PI (2015) Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clin Toxicol (Phila) 53:85–92CrossRef Wood DM, Sedefov R, Cunningham A, Dargan PI (2015) Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clin Toxicol (Phila) 53:85–92CrossRef
4.
go back to reference Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A (2015) Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Psychosomatics 56:129–139CrossRef Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A (2015) Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Psychosomatics 56:129–139CrossRef
8.
go back to reference Caspar AT, Helfer AG, Michely JA, Auwärter V, Brandt SD, Meyer MR, Maurer HH (2015) Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS. Anal Bioanal Chem 407:6697–6719CrossRef Caspar AT, Helfer AG, Michely JA, Auwärter V, Brandt SD, Meyer MR, Maurer HH (2015) Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS. Anal Bioanal Chem 407:6697–6719CrossRef
9.
go back to reference Boumrah Y, Humbert L, Phanithavong M, Khimeche K, Dahmani A, Allorge D (2016) In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS. Drug Test Anal 8:248–256CrossRef Boumrah Y, Humbert L, Phanithavong M, Khimeche K, Dahmani A, Allorge D (2016) In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS. Drug Test Anal 8:248–256CrossRef
10.
go back to reference Caspar AT, Westphal F, Meyer MR, Maurer HH (2018) LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques. Anal Bioanal Chem 410:897–912CrossRef Caspar AT, Westphal F, Meyer MR, Maurer HH (2018) LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques. Anal Bioanal Chem 410:897–912CrossRef
11.
go back to reference Nielsen LM, Holm NB, Leth-Petersen S, Kristensen JL, Olsen L, Linnet K (2017) Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Test Anal 9:671–679CrossRef Nielsen LM, Holm NB, Leth-Petersen S, Kristensen JL, Olsen L, Linnet K (2017) Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Test Anal 9:671–679CrossRef
12.
go back to reference Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J (2017) 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 9:680–698CrossRef Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J (2017) 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 9:680–698CrossRef
13.
go back to reference Temporal KH, Scott KS, Mohr ALA, Logan BK (2017) Metabolic profile determination of NBOMe compounds using human liver microsomes and comparison with findings in authentic human blood and urine. J Anal Toxicol 41:646–657CrossRef Temporal KH, Scott KS, Mohr ALA, Logan BK (2017) Metabolic profile determination of NBOMe compounds using human liver microsomes and comparison with findings in authentic human blood and urine. J Anal Toxicol 41:646–657CrossRef
14.
go back to reference Lee S, Kim IS, Kwak TH, Yoo HH (2013) Comparative metabolism study of β-lapachone in mouse, rat, dog, monkey, and human liver microsomes using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 83:286–292CrossRef Lee S, Kim IS, Kwak TH, Yoo HH (2013) Comparative metabolism study of β-lapachone in mouse, rat, dog, monkey, and human liver microsomes using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 83:286–292CrossRef
15.
go back to reference Bijlsma L, Sancho JV, Hernandez F, Niessen WM (2011) Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra. J Mass Spectrom 46:865–875CrossRef Bijlsma L, Sancho JV, Hernandez F, Niessen WM (2011) Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra. J Mass Spectrom 46:865–875CrossRef
Metadata
Title
Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry
Authors
Hyewon Seo
In Sook Kim
Young-Hoon Kim
Hye Hyun Yoo
Jin Hong
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 3/2019
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-018-1904-7

Other articles of this Issue 3/2019

International Journal of Legal Medicine 3/2019 Go to the issue